HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
暂无分享,去创建一个
J. Pawlotsky | M. Kowgier | C. Sarrazin | R. D. de Knegt | H. Janssen | H. Wedemeyer | T. Mazzulli | A. Duarte-Rojo | G. Garber | J. Feld | B. Maasoumy | G. Cloherty | J. Vermehren | F. Guerra | S. Bolotin | W. Wong | R. Maan | S. A. Al Marzooqi | M. van Tilborg | C. Flud
[1] Jean-Michel Pawlotsky,et al. EASL Recommendations on Treatment of Hepatitis C 2018. , 2018, Journal of hepatology.
[2] J. Pawlotsky,et al. Clinical Utility of HCV Core Antigen Detection and Quantification in the Diagnosis and Management of Patients with Chronic Hepatitis C Receiving an All-Oral, Interferon-Free Regimen , 2016, Antiviral therapy.
[3] Geoffrey Dusheiko,et al. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. , 2017, The lancet. Gastroenterology & hepatology.
[4] S. Taylor-Robinson,et al. Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania , 2017, Journal of the International AIDS Society.
[5] D. Nelson,et al. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. , 2017, Annals of internal medicine.
[6] J. Pawlotsky,et al. EASL Recommendations on Treatment of Hepatitis C 2016. , 2017, Journal of hepatology.
[7] A. Aghemo,et al. Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] M. Manns,et al. Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens. , 2016, Journal of hepatology.
[9] J. M. Freiman,et al. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection , 2016, Annals of Internal Medicine.
[10] S. Kassim,et al. The accuracy and cost‐effectiveness of hepatitis C core antigen assay in the monitoring of anti‐viral therapy in patients with chronic hepatitis C genotype 4 , 2015, Alimentary pharmacology & therapeutics.
[11] P. Paci,et al. The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[12] Dan J Stein,et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[13] T. Wong,et al. Cost-effectiveness of screening for hepatitis C in Canada , 2015, Canadian Medical Association Journal.
[14] D. Otelea,et al. Clinical usefulness of HCV core antigen assay for the management of patients with chronic hepatitis C. , 2014, Journal of gastrointestinal and liver diseases : JGLD.
[15] H. Tillmann. Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment. , 2014, World journal of gastroenterology.
[16] M. Buti,et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries , 2014, Journal of viral hepatitis.
[17] A. Huber,et al. Detection limit of architect hepatitis C core antigen assay in correlation with HCV RNA, and renewed confirmation algorithm for reactive anti-HCV samples. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[18] A. Berger,et al. Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] M. Manns,et al. Performance and clinical utility of a novel fully automated quantitative HCV-core antigen assay. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] R. Chung,et al. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] M. Mizokami,et al. High stability of enzyme immunoassay for hepatitis C virus core antigen-evaluation before and after incubation at room temperature. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.